CompoAtlas

VESSINAT FEMME

Food supplement declared in France, declaration No 2018-3-398, decision dated 9 March 2018

VESSINAT FEMME, from LAB NAT, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Cucurbita pepo 425 mg per day, Glycine max. 75 mg per day, Triglycérides à chaine moyenne. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LAB NAT
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Tablet
Daily dose
1 comprimé
Directions for use
1 comprimé le matin, à prendre avec un verre d'eau
Intended populations
People over 60, Women
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, History of breast cancer, Young children (aged 1 to 3), Pregnant women, Infants (under 1 year)
Objectives stated by the manufacturer (these are not authorised claims)
Urinary system

Declaration 287039, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Cucurbita pepo L.GraineExtrait sec hydroalcoolique425 mg
Glycine max. (L.) Merr.GraineExtrait sec hydroalcoolique75 mg

Other active ingredients

NamePer day
Triglycérides à chaine moyennenot declared

Additives

E504, E460, E341, E553b, E470b, E468, E464, E170, E1200, E120

Other ingredients

maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Tenir hors de portée des jeunes enfants. Ne pas dépasser la dose journalière conseillée. Les compléments alimentaires doivent être utilisés dans le cadre d'un mode de vie sain et ne pas être utilisés comme substituts d'un régime alimentaire varié et équilibré. Déconseillé chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein. Réservé à l'adulte. Déconseillé aux femmes enceintes ou allaitantes. A conserver dans un endroit sec, tempéré et à l'abri de la lumière.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “VESSINAT FEMME: composition and regulation”, https://compoatlas.com/en/supplements/products/287039-vessinat-femme, updated 15 November 2026.

List recorded in 2018. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line